2 page article in Resourcestocks magazine Jan-Feb issue.http://www.resourcestocks.com.au/profiles/corporateprofile.asp#JanFeb2010
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%